Bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new ...

This year, Novo Nordisk and Merck announced significant layoffs, with Novo planning to axe about 9,000 employees and Merck ...

The House Committee on Energy and Commerce has cleared proposed legislation that could bring back the FDA’s rare pediatric ...

BMO Capital Markets analysts said the first day of the CDC vaccine advisory committee meeting Thursday had anti-vaccine ...

After a tension-packed two days that saw recommended changes to the MMRV vaccine schedule and COVID-19 vaccine access, as ...

DB1, a capsid developed by Shape Therapeutics, to deliver therapies to the brain, including VectorY’s developmental ...

Nektar Therapeutics still needs to establish what differentiates rezpeg from other atopic dermatitis therapies, according to ...

The star of the acquisition, which includes a contingent value right of $6 per share, is pegozafermin, an FGF21 analog in ...

From a small team of researchers and skipped salaries, CEO Michelle Xia has steered Akeso to become one of the most exciting ...

Both BMS and Novo Nordisk have, in recent months, announced steep layoffs as they strive to cut back on costs.

The over-representation of males and Hispanic patients in Eli Lilly’s Phase III ATTAIN-1 study could explain why orforglipron ...

An IQVIA report published earlier this year found that 43% of anti-obesity assets currently in development are orally ...